Revenio Group Corporation: NOTICE PURSUANT TO SECTION 5, CHAPTER 9 OF THE SECURITIES MARKET ACT

Report this content
Revenio Group Corporation   Stock Exchange Release March 26, 2014 at 4.05 p.m.
NOTICE PURSUANT TO SECTION 5, CHAPTER 9 OF THE SECURITIES MARKET ACT

Revenio Group Corporation has today received a notification of change in
holdings in accordance with Chapter 9, Section 5 of the Securities Markets Act
that Eyemaker's Finland Oy's share of the total number of shares and voting
rights in Revenio Group Corporation has decreased to less than one twentieth
(1/20).

Eyemaker's Finland Oy now holds 350,000 shares in Revenio Group Corporation,
which is 4.45 percent of the company's shares and voting rights.

The total number of Revenio Group Corporation's shares recorded in the trade
register is 7,856,519.

Revenio Group Corporation

Olli-Pekka Salovaara
President and CEO

For further information, please contact:

Olli-Pekka Salovaara, President & CEO, +358 (0)40 567 5520 (mobile)
olli-pekka.salovaara@revenio.fi
http://www.revenio.fi/


DISTRIBUTION:

NASDAQ OMX Helsinki

Financial Supervisory Authority (FIN-FSA)

Principal media

www.revenio.fi



The Revenio Group in brief

Revenio is a Finnish health tech group whose core business is tonometers. The
Revenio Health Tech segment comprises the business operations of Icare Finland
Oy. The widely patented Icare product family is the current cornerstone of the
Group's success. Revenio seeks vigorous growth in health technology, both
organically and through acquisitions and mergers. The Revenio Group also
includes other business operations, which are grouped under the Technology and
Services segment. This segment's operations have a shared global market and
represent the cutting edge of technology products and services in their
industry. These businesses are extremely profitable in their industries and
generate positive cash flow.

In 2013, the Revenio Group's net sales totaled EUR 25.7 million, with its
operating margin standing at 21.7%. The Revenio Group Corporation is listed on
NASDAQ OMX Helsinki.